Down-regulation of prostate-specific antigen expression by finasteride through inhibition of complex formation between androgen receptor and steroid receptor-binding consensus in the promoter of the PSA gene in LNCaP cells

Cancer Research

Volumn 57, Issue 4, 1997, Pages 714-719

  Wang, Long Gui ^a   Liu, Xiao Mei ^a   Kreis, Willi ^a,b   Budman, Daniel R ^a  

^a NEW YORK UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; FINASTERIDE; PROSTATE SPECIFIC ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; BINDING AFFINITY; COMPETITIVE INHIBITION; COMPLEX FORMATION; DNA PROTEIN COMPLEX; DRUG RECEPTOR BINDING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; OLIGONUCLEOTIDE PROBE; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR DOWN REGULATION; REGULATOR GENE; TATA BOX;

CONSENSUS SEQUENCE; DOWN-REGULATION; FINASTERIDE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; MALE; PROMOTER REGIONS (GENETICS); PROSTATE-SPECIFIC ANTIGEN; RECEPTORS, ANDROGEN; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0009413722     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Sudduth, S. L., and Koronkowski, M. J. Finasteride: the first 5α-reductase inhibitor. Pharmacotherapy, 13: 309-329, 1993.
2. Bologna, M., Muzi, P., Biordi, L., Festuccia, C., and Vicentini, C. Finasteride dose-dependently reduces the proliferation rate of the LNCaP human prostatic cancer cell line in vitro. Urology, 45: 282-290, 1995.
3. Kreis, W., Budman, D. R., Calabro, A., Wang, L. G., and Liu, X. M. Combined effects of estramustine (EM) and other estramustine phosphates (BMP) with other antitumor agents in 3 established cell lines derived from prostate cancer (PC). Proceedings of the 9th National Cancer Institute-European Organization for Research and Treatment of Cancer Symposium on New Drugs in Cancer Therapy, p. 46. Amsterdam (4755): Kluher Academic Publishers, Dordrecht, 1996.
4. Papsidero, L. D., Wang, M. C., Kuriyama, M., Horoszewicz, J. S., Leong, S. S., Croghan, G. A., Valenzuela, L. A., Murphy, G. P., and Chu, T. M. Human prostate epithelial cell-specific antigen. Proc. Clin, Biol. Res., 75A: 435-443, 1981.
5. Watt, K. W., Lee, P. J., M'Timkulu, T., Chan, W. P., and Loor, R. Human prostate-specific antigen: structural and functional similarity with serine proteases. Proc. Natl. Acad. Sci. USA, 83: 3166-3170, 1986.
6. Stamey, T. A., Ekman, P. E., Blankenstein, M. A., Cooper, E. H., Kontturi, M., Lilja, H., Oesterling, J. E., Stenman, U. H., and Turkes, A. Tumor makers. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.
7. Wang, L. G., Liu, X. M., Kreis, W., and Budman, D. R. Involvement of prostate specific antigen in the stimulation of LNCaP cell growth, Oncol. Rep., 3: 911-917, 1996.
8. Young, C Y-F., Montgomery, B. T., Andrews, P. E., Qui S. D., Bilhartz, D. L., and Tindall, D. J. Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP. Cancer Res., 51: 3748-3752, 1991.
9. Henttu, P., Liao, S., and Vihko, P. Androgen up-regulate the human prostate-specific antigen messenger ribonucleic acid (mRNA), but down-regulate the prostatic acid phosphatase mRNA in the LNCaP cell line. Endocrinology, 130: 766-772, 1992.
10. Henttu, P., and Vihko, P. Growth factor regulation of gene expression in the human prostatic carcinoma cell line LNCaP. Cancer Res., 53: 1051-1058, 1993.
11. Lundwall, A. Characterization of the gene for prostate-specific antigen, a human glandular kallikrein. Biochem. Biophys. Res. Commun., 161: 1151-1159, 1989.
12. Riegman, P. H., Vlietstra, R. J., van der Korput, J. A., Romijn, J. C., and Trapman, J. Characterization of the prostate-specific antigen gene: a novel human kallikrein-like gene. Biochem. Biophys. Res. Commun. 159: 95-102, 1989.
13. Riegman, P. H., Vlietstra, R. J., van der Korput, J. A., Brinkmann, A. O., and Trapman, J. The promoter of the prostate-specific antigen gene contains a functional androgen responsive element Mol. Endocrinol., 5: 1921-1930, 1991.
14. Klobeck, H. G., Combriato, G., Schulz, P., Arbusow, V., and Fittier, F. Genomic sequence of human prostate specific antigen (PSA). Nucleic Acids Res., 17: 3981, 1989.
15. Wang, L. G., Liu, X. M., Li, Z, R., Denstman, S., and Bloch, A. Differential binding of nuclear c-ets-1 protein to an intron I fragment of the c-myb gene in growth versus differentiation. Cell Growth & Differ., 5: 1243-1251, 1994.
16. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolated by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
17. Luke, M C., and Coffey, D. S. Human androgen receptor binding to the androgen response element of prostate specific antigen. J. Androl., 15: 41-51, 1994.
18. Gormley, G. J., Stoner, E., Bruskewitz, R. C., Imperato-McGinley, J., Walsh, P. C., McConnell, J. D., Andriole, G. L., Bracken, B. R., Tenover, J. S., Vaughan, E. D., Taylor, A., Binkowitz, B., and Ng, J. The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Group. N. Engl. J. Med., 327: 1185-1191, 1992.
19. Guess, H. A., Gormley, G. J., Stoner, E., and Oesterling, J. E. The effect of finasteride on the prostate specific antigen: review of available data. J. Urol., 155: 3-9, 1996.
20. Presti, J. C., Jr., Fair, W. R., Andriole, G., Sogani, P. C, Seidmon, E. J., Ferguson, D., Ng, J., and Gormley, G. J, Multicenter, randomized, double-blind, placebo controlled study to investigate the effect of fmasteride (MK-906) on stage D prostate cancer. J. Urol., 148: 1201-1204, 1992.
21. Fawell, S. E., White, R., Hoare, S., Sydenham, M, Page M., and Parker, M. G. Inhibition of estrogen receptor-DNA binding by the "pure" antiestrogen ICI 164,384 appears to be mediated by impaired receptor dimerization. Proc. Natl. Acad. Sci. USA, 87: 6883-6887, 1990.
22. Fawell, S. E., Lees, J. A., White, R., and Parker, M. G. Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor. Cell, 60: 953-962, 1990.
23. Roche, P. J., Hoare, S. A., and Parker, M. G. A consensus DNA-binding site for the androgen receptor. Mol. Endocrinol., 6: 2229-2235, 1992.
24. Lubahn, D. B., Joseph, D. R., Sullivan, P. M., Willard, H. F., French, F. S., and Wilson, E. M. Cloning of human androgen receptor complementary DNA and localization to the X chromosome. Science (Washington DC), 240: 327-330, 1988.
25. Chang, C., and Kokontis, J, Identification of a new member of the steroid receptor super-family by cloning and sequence analysis. Biochem. Biophys. Res. Commun., 155: 971-977, 1988.
26. Wolf, D. A., Schulz, P., and Fittler, F. Transcriptional regulation of prostate kallikrein-like genes by androgen, Mol. Endocrinol., 6: 753-762, 1992.
27. Beato, M. Gene regulation by steroid hormones. Cell, 56: 335-344, 1989.
28. Carson-Jurica, M. A., Schrader, W. T., and O'Malley, B. W. Steroid receptor family: structure and functions. Endocr. Rev., 11: 201-220, 1990.
29. Evans, R. M. The steroid and thyroid hormone receptor superfamily. Science (Washington DC), 240: 889-895, 1988.
30. Ham, J., and Parker, M. G. Regulation of gene expression by nuclear hormone receptors. Curr. Opin. Cell Biol., 1: 503-511, 1989.